Review Article

Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents

Table 3

Classification of LBDDS their characteristics, advantages, and disadvantages [123, 124].

Formulation classClass 1Class IIClass IIIA (fine emulsion)Class IIIB (microemulsion)Class IV

Materials used in formulationOils without surfactantsOils and O/W soluble surfactantsLipid/oils, surfactants-cosurfactant ratio, cosolvents (both aqueous soluble and insoluble components)Lipid/oils, surfactants-cosurfactant ratio, cosolvents (both aqueous soluble and insoluble components)Water-soluble surfactants and cosolvents (no oils)
CharacteristicsNondispersibleEmulsification (SEDDS) with aqueous-insoluble substancesSEDDS/SNEDDS/SMEDDS molded using aqueous solvable substancesSEDDS/SMEDDS formed using aqueous soluble substances and the amount of oil is lessDisperses classically to produce a micelles solution
Digestion characteristicRequires digestionIngested easilyIngestion not essentialIngestion not compulsoryPartial ingestion
AdvantagesSimple GRAS capsule compatibilityUnlikely, on dispersion loose solvent capacityOn dispersion, clear or almost clear dispersionOn dispersion, clear or almost clear dispersion(i) Formulation has good solvent capability
DisadvantagesPoor solvent capabilityRelatively coarse O/W dispersion, ingestion probably but not decisiveOn dispersion, possibility is loose of solvent capability or ingestionOn dispersion, possibility is loose of solvent capability or ingestionOn dispersion, possibility is loose of solvent capability